Your browser doesn't support javascript.
loading
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study.
Yasumatsu, Ryuji; Shimizu, Yasushi; Hanai, Nobuhiro; Kariya, Shin; Yokota, Tomoya; Fujii, Takashi; Tsukahara, Kiyoaki; Ando, Mizuo; Hanyu, Kenji; Ueda, Tsutomu; Hirakawa, Hitoshi; Takahashi, Shunji; Ono, Takeharu; Sano, Daisuke; Yamauchi, Moriyasu; Watanabe, Akihito; Omori, Koichi; Yamazaki, Tomoko; Monden, Nobuya; Kudo, Naomi; Arai, Makoto; Yonekura, Syuji; Asakage, Takahiro; Nekado, Takahiro; Yamada, Takayuki; Homma, Akihiro.
Afiliação
  • Yasumatsu R; Department of Otolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Shimizu Y; Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Hanai N; Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Kariya S; Department of Otolaryngology, Head and Neck Surgery, Okayama University Hospital, Okayama, Japan.
  • Yokota T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Fujii T; Department of Head and Neck Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Tsukahara K; Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
  • Ando M; Otorhinolaryngology and Head and Neck Surgery, The University of Tokyo Hospital, Tokyo, Japan.
  • Hanyu K; Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Okayama, Japan.
  • Ueda T; Head and Neck Oncology Center, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.
  • Hirakawa H; Department of Otorhinolaryngology, Head and Neck Surgery, Hiroshima University Hospital, Hiroshima, Japan.
  • Takahashi S; Department of Otorhinolaryngology, Head and Neck Surgery, University of the Ryukyus Hospital, Okinawa, Japan.
  • Ono T; Department of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Sano D; Department of Otolaryngology, Head and Neck Surgery, Kurume University Hospital, Kurume, Japan.
  • Yamauchi M; Otolaryngology, Head and Neck Surgery, Yokohama City University Hospital, Yokohama, Japan.
  • Watanabe A; Department of Otolaryngology, Head and Neck Surgery, Saga University Hospital, Saga, Japan.
  • Omori K; Department of Otolaryngology, Head and Neck Surgery, Keiyukai Sapporo Hospital, Sapporo, Japan.
  • Yamazaki T; Department of Otolaryngology, Head and Neck Surgery, Kyoto University Hospital, Kyoto, Japan.
  • Monden N; Division of Head and Neck Cancer Oncology, Miyagi Cancer Center, Sendai, Japan.
  • Kudo N; Department of Head and Neck Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Arai M; Department of Otorhinolaryngology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Yonekura S; Department of Medical Oncology, Chiba University Hospital, Chiba, Japan.
  • Asakage T; Department of Otorhinolaryngology, Head and Neck Surgery, Chiba University Hospital, Chiba, Japan.
  • Nekado T; Department of Head and Neck Surgery, Tokyo Medical and Dental University Medical Hospital, Tokyo, Japan.
  • Yamada T; Medical Affairs, Ono Pharmaceutical Co., Ltd, Osaka, Japan.
  • Homma A; Japan Medical and Development, Bristol-Myers Squibb K.K, Tokyo, Japan.
Int J Clin Oncol ; 27(1): 95-104, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34773525
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Neoplasias de Cabeça e Pescoço Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Int J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Neoplasias de Cabeça e Pescoço Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Int J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão